Experience of desmopressin (DDAVP) administration in patients with congenital and acquired bleeding disorders.

  • W L Tsay, M C Shen
  • Published 1992 in
    Journal of the Formosan Medical Association…

Abstract

Desmopressin (DDAVP) 0.3 micrograms/kg was administered intravenously to three normal volunteers and 12 patients with von Willebrand's disease (vWD), congenital or acquired platelet function defect, or uremic bleeding to assess its effects and side effects. DDAVP significantly shortened the bleeding time as compared with basal values. The mean peak post… (More)

Topics

Cite this paper

@article{Tsay1992ExperienceOD, title={Experience of desmopressin (DDAVP) administration in patients with congenital and acquired bleeding disorders.}, author={W L Tsay and M C Shen}, journal={Journal of the Formosan Medical Association = Taiwan yi zhi}, year={1992}, volume={91 10}, pages={962-9} }